Press
Releases
Title
Date
Download PDF
Dr. Cezar Khursigara, PhD Joins PUF Ventures Advisory Board
04/24/2018
PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.
04/18/2018
PUF Ventures Inc. Announces a Plan to Spin Out its Subsidiary Natures Hemp Inc.
04/04/2018
PUF Ventures Announces Stock Option Grants.
03/29/2018
Solaris Nutraceuticals Receives AUD$2,500,000 Grant from Federal Department of Innovation, Industry & Science
02/15/2018
Cannvas Medtech Inc. Forms Technology Partnership with Blox Labs for Digital Marketing and Branding
02/01/2018
PUF Ventures to Submit Confirmation of Readiness for a Licence Under the ACMPR for London, Ontario Facility
01/26/2018
Puf Ventures Announces Closing Of Plan Of Arrangement With Cannvas Medtech Inc.
01/16/2018
Australia to Allow Exportation of Cannabis Products
01/05/2018
PUF Ventures Announces Stock Option Grants
12/29/2017
PUF Ventures Announces Application Acceptance and Name Change of PUF Ventures Australia
12/21/2017
PUF Ventures Australia Files for Medical Research License in Collaboration with Western Sydney University
12/04/2017
PUF Ventures Announces Receipt of Final Order for Plan of Arrangement
11/30/2017
PUF Ventures Reports Annual General and Special Meeting Results
11/27/2017
PUF Ventures Australia Engages Dutch Greenhouse Builder KUBO to Construct Advanced Cannabis Production Facility
11/21/2017
PUF Ventures Provides Corporate Update
11/14/2017
PUF Ventures Australia Files Office of Drug Control Applications in Australia. Expands Grow Facility Plan by 20%
11/14/2017
PUF Ventures to Acquire Hemp Based Food and Medicinal Product Lines
10/12/2017
PUF Ventures Prepares Health Canada Proof of Readiness Submission For Grow Facility in London Ontario
10/04/2017
PUF Ventures Provides Update to Plan of Arrangement with Weed Points Loyalty Inc.
09/29/2017